Cargando…

Trends in Stroke Prevention between 2014 and 2018 in Hospitalized Atrial Fibrillation Patients

In recent years, significant changes in stroke prophylaxis in patients with atrial fibrillation (AF) have been observed. Non-vitamin K antagonist oral anticoagulants (NOACs) are more commonly used in the prevention of thromboembolic complications in patients with AF. The aim of the study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bielecka, B., Gorczyca, I., Jelonek, O., Wożakowska-Kapłon, B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886594/ https://www.ncbi.nlm.nih.gov/pubmed/33628491 http://dx.doi.org/10.1155/2021/6657776

Ejemplares similares

Nine-Year Trends in Prevention of Thromboembolic Complications in Elderly Patients with Atrial Fibrillation Treated with NOACs
por: Bielecka, Bernadetta, et al.
Publicado: (2022)

Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

Temporal Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients between 2004 and 2019
por: Gorczyca-Głowacka, Iwona, et al.
Publicado: (2022)

Long-Term Outcomes after Stroke in Patients with Atrial Fibrillation: A Single Center Study
por: Tracz, Justyna, et al.
Publicado: (2023)

Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Left atrial wall dyskinesia assessed during contractile phase as a predictor of atrial fibrillation recurrence after electrical cardioversion performed due to persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

New oral anticoagulants – will they be used with antiplatelet drugs in patients with atrial fibrillation after acute coronary syndrome?
por: Gorczyca-Michta, Iwona, et al.
Publicado: (2013)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Risk of left atrial appendage thrombus in older patients with atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2021)

Risk of left atrial appendage thrombus in patients with atrial fibrillation and chronic kidney disease
por: Budnik, Monika, et al.
Publicado: (2022)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szpotowicz, Anna, et al.
Publicado: (2021)

Do Patients with Atrial Fibrillation and a History of Ischemic Stroke Overuse Reduced Doses of NOACs?—Results of the Polish Atrial Fibrillation (POL-AF) Registry
por: Szyszkowska, Anna, et al.
Publicado: (2022)

Left Ventricular Ejection Fraction Is Associated with the Risk of Thrombus in the Left Atrial Appendage in Patients with Atrial Fibrillation
por: Uziębło-Życzkowska, Beata, et al.
Publicado: (2020)

Elective cardioversion of atrial fibrillation is safe without transesophageal echocardiography in patients treated with non-vitamin K antagonist oral anticoagulants: Multicenter experience
por: Gorczyca, Iwona, et al.
Publicado: (2023)

Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation
por: Wałek, Paweł, et al.
Publicado: (2020)

Anticoagulant Treatment in Patients with AF and Very High Thromboembolic Risk in the Era before and after the Introduction of NOAC: Observation at a Polish Reference Centre
por: Bielecka, Bernadetta, et al.
Publicado: (2023)

Left Atrial Appendage Thrombus Formation Despite Continuous Non-Vitamin K Antagonist Oral Anticoagulant Therapy in Atrial Fibrillation Patients Undergoing Electrical Cardioversion or Catheter Ablation: A Comparison of Dabigatran and Rivaroxaban
por: Gorczyca, Iwona, et al.
Publicado: (2020)

Left Atrial Wall Motion Velocity Assessed during Atrial Fibrillation Predicts Sinus Rhythm Maintenance after Electrical Cardioversion in Patients with Persistent Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2022)

Does the CHA(2)DS(2)-VASc scale sufficiently predict the risk of left atrial appendage thrombus in patients with diagnosed atrial fibrillation treated with non-vitamin K oral anticoagulants?
por: Michalska, Anna, et al.
Publicado: (2020)

Symptomatic and Asymptomatic Patients in the Polish Atrial Fibrillation (POL-AF) Registry
por: Kiliszek, Marek, et al.
Publicado: (2021)

Persistent atrial fibrillation is not associated with thrombomodulin level increase in efficiently anticoagulated patients
por: Wożakowska-Kapłon, Beata, et al.
Publicado: (2010)

Echocardiographic Evaluation of Atrial Remodelling for the Prognosis of Maintaining Sinus Rhythm after Electrical Cardioversion in Patients with Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2023)

Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014
por: Jain, Vageesh, et al.
Publicado: (2017)

Hyperuricemia as a Marker of Reduced Left Ventricular Ejection Fraction in Patients with Atrial Fibrillation: Results of the POL-AF Registry Study
por: Wełnicki, Marcin, et al.
Publicado: (2021)

Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
por: Wałek, Paweł, et al.
Publicado: (2021)

Association of Hyperuricemia with Impaired Left Ventricular Systolic Function in Patients with Atrial Fibrillation and Preserved Kidney Function: Analysis of the POL-AF Registry Cohort
por: Wełnicki, Marcin, et al.
Publicado: (2022)

Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
por: Gawałko, Monika, et al.
Publicado: (2021)

Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018)

Trends in the rates of hospitalizations for acute stroke among patients over 90 years of age with atrial fibrillation in the United States: from 2005 to 2014
por: Shantha, Ghanshyam PS, et al.
Publicado: (2017)

Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
por: Patel, Taral K., et al.
Publicado: (2012)

Improving stroke prevention in patients with atrial fibrillation
por: Arts, Derk L, et al.
Publicado: (2013)

Stroke Prevention in Atrial Fibrillation: Concepts and Controversies
por: Ahmad, Yousif, et al.
Publicado: (2012)

Emerging Tools for Stroke Prevention in Atrial Fibrillation
por: Voukalis, Christos, et al.
Publicado: (2016)

Non-Pharmacological Stroke Prevention in Atrial Fibrillation
por: Anduaga, Iñigo, et al.
Publicado: (2023)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Costs of Stroke and Incidence of First Diagnosis of Atrial Fibrillation at Time of Stroke. Neurology Ward Hospital Poznań, Poland 2018
por: Zaprutko, Tomasz, et al.
Publicado: (2021)

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
por: De Backer, O, et al.
Publicado: (2014)

Left Atrial Appendage Closure to Prevent Strokes and Ligation to Prevent Atrial Fibrillation
por: Ellis, Christopher R.
Publicado: (2017)

Trends in Cardiovascular Mortality Related to Atrial Fibrillation in the United States, 2011 to 2018
por: Tanaka, Yoshihiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8ujmqirjnnticp26ofig5927r1